82 related articles for article (PubMed ID: 38576043)
1. Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab.
Wang F; Liao W; Li C; Zhu L
Int Immunopharmacol; 2024 Jun; 134():112187. PubMed ID: 38733825
[TBL] [Abstract][Full Text] [Related]
2. Dioscin decreases M2 polarization via inhibiting a positive feedback loop between RBM47 and NF-κB in glioma.
Bai J; Zhang X; Meng W; Xu H; Liu Y; Zhong Y; Lin X; Wang J; Fan D; Lv G; Gu Y
Phytomedicine; 2024 Jun; 128():155417. PubMed ID: 38518642
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
Wei X; Nie S; Liu H; Sun J; Liu J; Li J; Li S; Wang S; Han S; Wang J; Sun Y
Am J Cancer Res; 2017; 7(11):2220-2233. PubMed ID: 29218246
[TBL] [Abstract][Full Text] [Related]
4. Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer.
Boufaied N; Chetta P; Hallal T; Cacciatore S; Lalli D; Luthold C; Homsy K; Imada EL; Syamala S; Photopoulos C; Di Matteo A; de Polo A; Storaci AM; Huang Y; Giunchi F; Sheridan PA; Michelotti G; Nguyen QD; Zhao X; Liu Y; Davicioni E; Spratt DE; Sabbioneda S; Maga G; Mucci LA; Ghigna C; Marchionni L; Butler LM; Ellis L; Bordeleau F; Loda M; Vaira V; Labbé DP; Zadra G
Cancer Res; 2024 Jun; 84(11):1834-1855. PubMed ID: 38831751
[TBL] [Abstract][Full Text] [Related]
5. Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression.
Zong S; Li X; Zhang G; Hu J; Li H; Guo Z; Zhao X; Chen J; Wang Y; Jing Z
Phytomedicine; 2024 May; 130():155611. PubMed ID: 38776737
[TBL] [Abstract][Full Text] [Related]
6. TRIM6 promotes glioma malignant progression by enhancing FOXO3A ubiquitination and degradation.
Guo J; Wang J; Zhang P; Wen P; Zhang S; Dong X; Dong J
Transl Oncol; 2024 May; 46():101999. PubMed ID: 38759605
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter?
Seidu RA; Wu M; Su Z; Xu H
Oncol Rev; 2017 Mar; 11(1):325. PubMed ID: 28382190
[TBL] [Abstract][Full Text] [Related]
8. Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor.
Barrett J; Leysen S; Galmiche C; Al-Mossawi H; Bowness P; Edwards TE; Lawson ADG
Bioengineered; 2024 Dec; 15(1):2299522. PubMed ID: 38184821
[TBL] [Abstract][Full Text] [Related]
9. A functional variant rs10409772 in FUT6 promoter regulates colorectal cancer progression through PKA/CREB signaling.
Zhang J; Song Q; Hu W
Transl Oncol; 2024 May; 46():102011. PubMed ID: 38823257
[TBL] [Abstract][Full Text] [Related]
10. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
[TBL] [Abstract][Full Text] [Related]
11. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
12. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression.
Yan C; Yang Z; Chen P; Yeh Y; Sun C; Xie T; Huang W; Zhang X
J Exp Clin Cancer Res; 2024 Apr; 43(1):105. PubMed ID: 38576043
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression.
Gao X; Zhou S; Qin Z; Li D; Zhu Y; Ma D
J Transl Med; 2023 Jan; 21(1):53. PubMed ID: 36709284
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 Positive Feedback Loop Between Cancer Cells and Tumor-Associated Macrophages Promotes Osteosarcoma Migration and Invasion.
Hou C; Lu M; Lei Z; Dai S; Chen W; Du S; Jin Q; Zhou Z; Li H
Lab Invest; 2023 May; 103(5):100054. PubMed ID: 36801636
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]